These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15544436)

  • 1. Human hepatocytes in primary culture: the choice to investigate drug metabolism in man.
    Gómez-Lechón MJ; Donato MT; Castell JV; Jover R
    Curr Drug Metab; 2004 Oct; 5(5):443-62. PubMed ID: 15544436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies.
    Donato MT; Castell JV
    Clin Pharmacokinet; 2003; 42(2):153-78. PubMed ID: 12537515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hepatic cell cultures: in vitro and in vivo drug metabolism.
    Gómez-Lechón MJ; Donato T; Ponsoda X; Castell JV
    Altern Lab Anim; 2003; 31(3):257-65. PubMed ID: 15612868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human hepatocytes as a tool for studying toxicity and drug metabolism.
    Gómez-Lechón MJ; Donato MT; Castell JV; Jover R
    Curr Drug Metab; 2003 Aug; 4(4):292-312. PubMed ID: 12871046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies.
    Schulz C; Kammerer S; Küpper JH
    Clin Hemorheol Microcirc; 2019; 73(1):249-260. PubMed ID: 31561354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of human hepatocytes to investigate drug metabolism and CYP enzyme induction.
    Klieber S; Torreilles F; Guillou F; Fabre G
    Methods Mol Biol; 2010; 640():295-308. PubMed ID: 20645059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
    Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hepatocytes to investigate UDP-glucuronosyltransferases and sulfotransferases.
    Fournel-Gigleux S; Coughtrie MW; Ouzzine M; Magdalou J
    Methods Mol Biol; 2010; 640():309-26. PubMed ID: 20645060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on metabolism studies using human hepatocytes in primary culture.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):837-54. PubMed ID: 18624674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes.
    Cohen LH; van Leeuwen RE; van Thiel GC; van Pelt JF; Yap SH
    Biopharm Drug Dispos; 2000 Dec; 21(9):353-64. PubMed ID: 11523064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demethylation of radiolabelled dextromethorphan in rat microsomes and intact hepatocytes.
    Di Marco A; Yao D; Laufer R
    Eur J Biochem; 2003 Sep; 270(18):3768-77. PubMed ID: 12950260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction.
    Kumar G; Lau H; Laskin O
    Cancer Chemother Pharmacol; 2009 May; 63(6):1171-5. PubMed ID: 19030860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct comparison of UDP-glucuronosyltransferase and cytochrome P450 activities in human liver microsomes, plated and suspended primary human hepatocytes from five liver donors.
    den Braver-Sewradj SP; den Braver MW; Baze A; Decorde J; Fonsi M; Bachellier P; Vermeulen NPE; Commandeur JNM; Richert L; Vos JC
    Eur J Pharm Sci; 2017 Nov; 109():96-110. PubMed ID: 28778465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro profiling of the metabolism and drug-drug interaction of tofogliflozin, a potent and highly specific sodium-glucose co-transporter 2 inhibitor, using human liver microsomes, human hepatocytes, and recombinant human CYP.
    Yamane M; Kawashima K; Yamaguchi K; Nagao S; Sato M; Suzuki M; Honda K; Hagita H; Kuhlmann O; Poirier A; Fowler S; Funk C; Simon S; Aso Y; Ikeda S; Ishigai M
    Xenobiotica; 2015 Mar; 45(3):230-8. PubMed ID: 25350082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of drug-drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction.
    Li AP; Maurel P; Gomez-Lechon MJ; Cheng LC; Jurima-Romet M
    Chem Biol Interact; 1997 Nov; 107(1-2):5-16. PubMed ID: 9402946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of cytochrome 450 mediated drug-drug interactions by three-dimensional cultured hepatocytes.
    Shen C; Meng Q
    Mini Rev Med Chem; 2012 Sep; 12(10):1028-36. PubMed ID: 22512564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell lines: a tool for in vitro drug metabolism studies.
    Donato MT; Lahoz A; Castell JV; Gómez-Lechón MJ
    Curr Drug Metab; 2008 Jan; 9(1):1-11. PubMed ID: 18220566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Human Hepatic Clearance for Cytochrome P450 Substrates via a New Culture Method Using the Collagen Vitrigel Membrane Chamber and Fresh Hepatocytes Isolated from Liver Humanized Mice.
    Watari R; Kakiki M; Yamasaki C; Ishida Y; Tateno C; Kuroda Y; Ishida S; Kusano K
    Biol Pharm Bull; 2019; 42(3):348-353. PubMed ID: 30828066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery.
    Sahi J; Grepper S; Smith C
    Curr Drug Discov Technol; 2010 Sep; 7(3):188-98. PubMed ID: 20843293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.